HydraMed vs MEDVi
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
HydraMed
Best for patients wanting all-in pricing with a single intake feeStarting at $179/mo
MEDVi
Best for mainstream telehealth GLP-1 accessStarting at $179/mo
Side-by-Side Comparison
| Feature | HydraMed | MEDVi |
|---|---|---|
| Overall Score | ✓7.9/10 | 7.2/10 |
| Starting Price | $179/mo | $179/mo |
| Customer Rating | — | — |
| Features | ✓6 features | 3 features |
| States Available | 50 | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
HydraMed
Pros
- ✓All-inclusive pricing with no add-ons
- ✓Free shipping
- ✓US FDA-registered compounding pharmacy
- ✓Quick intake process
Cons
- ✗Wide peptide menu beyond GLP-1s — patients should stay focused on FDA-approved indications
- ✗Trust score moderate pending more independent verification
MEDVi
Pros
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
Cons
- ✗Limited public information on program details
Our Verdict
HydraMed edges out MEDVi with a higher overall score of 7.9/10 and is particularly strong for patients wanting all-in pricing with a single intake fee. MEDVi remains a solid alternative, especially if you're looking for mainstream telehealth GLP-1 access.
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.